LIEN DO: Open Payments
NPI 1922450477 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 5 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $110 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $186 |
| Alnylam Pharmaceuticals Inc. | 3 | $66 |
| Lilly USA, LLC | 1 | $30 |
Products named: REZDIFFRA, ONPATTRO, OMVOH.
Industry payments across CA — which companies pay providers there.
